The effects on mineral metabolism of therapeutic doses of corticosteroids were investigated in infantile cortical hyperostosis; in four untreated cases the calcium, phosphorus, and magnesium balances were strongly positive. In one severe case, treatment with prednisolone was associated with an alteration to negative calcium and magnesium balance, and faecal losses of calcium were particularly high. This effect persisted for at least three months after the steroids had been discontinued, and during this period there was pronounced retardation of linear growth. Six months after the treatment had been stopped mineral balance was again positive and there was rapid 'catch up' in growth.
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Abstract
The effects on mineral metabolism of therapeutic doses of corticosteroids were investigated in infantile cortical hyperostosis; in four untreated cases the calcium, phosphorus, and magnesium balances were strongly positive. In one severe case, treatment with prednisolone was associated with an alteration to negative calcium and magnesium balance, and faecal losses of calcium were particularly high. This effect persisted for at least three months after the steroids had been discontinued, and during this period there was pronounced retardation of linear growth. Six months after the treatment had been stopped mineral balance was again positive and there was rapid 'catch up' in growth.
In infancy, the negative effect of corticosteroids on calcium, phosphorus, and magnesium metabolism may contribute to inhibition of bone growth and steroid stunting.
We know of few biochemical studies in infantile cortical hyperostosis. Serum calcium and phosphorus concentrations are normal but alkaline phosphatase activity is usually increased during the active phase.' Aminoaciduria has been reported in one case. 2 Corticosteroid treatment has been advised with reservation3'4 but recommended for all patients,' 5particularly for severe cases. 6 In this study of infantile cortical hyperostosis one case, whose growth was studied longitudinally, had a series of balance studies for calcium, phosphorus, and magnesium before, during, and after treatment with corticosteroids. Three other cases not receiving steroids had single balance studies. Off treatment for three months 5*8
Six months after end of steroid treatment 9 9 Clinical onset aged 9 weeks Generalised disease; relapse at age 4 months Clinical onset aged 11 weeks Localised disease Clinical onset aged 4 18 20 Calcium depletion complicating treatment with steroids in children has been described. '5 16 27 have all been implicated. Vitamin D seemed to enhance catch up growth after courses of steroids in rats treated with cortisone. 28 During rapid development of the skeleton in infancy, the side effects of steroids on linear growth and mineral metabolism might be especially undesirable.
This study suggests that mineral depletion by corticosteroids may be severe and prolonged in infancy contributing to the inhibition of bone growth. Mineral supplements, with or without vitamin D, might help to offset these mineral losses and mitigate the stunting effects of steroids.
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